Concerns about the approval of nusinersen sodium by the US food and drug administration

Martha S. Gerrity, Vinay Prasad, Adam J. Obley

Research output: Contribution to journalComment/debate

5 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)743-744
Number of pages2
JournalJAMA Internal Medicine
Volume178
Issue number6
DOIs
StatePublished - Jun 1 2018

Fingerprint

United States Food and Drug Administration
Sodium

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Concerns about the approval of nusinersen sodium by the US food and drug administration. / Gerrity, Martha S.; Prasad, Vinay; Obley, Adam J.

In: JAMA Internal Medicine, Vol. 178, No. 6, 01.06.2018, p. 743-744.

Research output: Contribution to journalComment/debate

@article{a6aab1ed0c24442082d14a4306b1eda6,
title = "Concerns about the approval of nusinersen sodium by the US food and drug administration",
author = "Gerrity, {Martha S.} and Vinay Prasad and Obley, {Adam J.}",
year = "2018",
month = "6",
day = "1",
doi = "10.1001/jamainternmed.2018.0869",
language = "English (US)",
volume = "178",
pages = "743--744",
journal = "JAMA Internal Medicine",
issn = "2168-6106",
publisher = "American Medical Association",
number = "6",

}

TY - JOUR

T1 - Concerns about the approval of nusinersen sodium by the US food and drug administration

AU - Gerrity, Martha S.

AU - Prasad, Vinay

AU - Obley, Adam J.

PY - 2018/6/1

Y1 - 2018/6/1

UR - http://www.scopus.com/inward/record.url?scp=85048803243&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048803243&partnerID=8YFLogxK

U2 - 10.1001/jamainternmed.2018.0869

DO - 10.1001/jamainternmed.2018.0869

M3 - Comment/debate

C2 - 29710299

AN - SCOPUS:85048803243

VL - 178

SP - 743

EP - 744

JO - JAMA Internal Medicine

JF - JAMA Internal Medicine

SN - 2168-6106

IS - 6

ER -